共查询到20条相似文献,搜索用时 0 毫秒
1.
Chae Jo Lim Ji Young Kim Byung Ho Lee Kwang-Seok Oh Kyu Yang Yi 《Bioorganic & medicinal chemistry letters》2013,23(6):1736-1739
The discovery and optimization of novel pyrrolo[3,4-b]pyridin-7(6H)-one MCH-R1 antagonists are described. A systematic SAR study probing the effects of aryl-, benzyl- and arylthio-substituents at the 2-position of the pyrrolo[3,4-b]pyridin-7(6H)-ones led to identification of the 2-[(4-fluorophenyl)thio] derivative 7b as a highly potent MCH-R1 antagonist. This compound also has favorable pharmacokinetic properties along with a high metabolic stability and a minimal impact on CYP isoforms and hERG. 相似文献
2.
Palani A Shapiro S McBriar MD Clader JW Greenlee WJ O'Neill K Hawes B 《Bioorganic & medicinal chemistry letters》2005,15(23):5234-5236
Herein, we report the discovery of the potent and selective biaryl diamide derived MCH-R1 receptor antagonist 1, which was identified upon modification of a previously disclosed biaryl urea series. This paper describes one of the strategies incorporated to remove the highly mutagenic biarylaniline present in an otherwise promising biaryl urea series. 相似文献
3.
Guo T Gu H Hobbs DW Busler DE Rokosz LL 《Bioorganic & medicinal chemistry letters》2007,17(6):1718-1721
Melanin concentrating hormone (MCH) plays an important role in the regulation of food intake and energy balance in mammals. MCH-1 receptor (MCH1R) deficient mice are lean and resistant to diet-induced obesity. As such, MCH1R antagonists are believed to have potential as possible treatments for obesity. The discovery of a novel class of tetralin ureas as potent MCH1R antagonists is described herein. 相似文献
4.
Berglund S Egner BJ Gradén H Gradén J Morgan DG Inghardt T Giordanetto F 《Bioorganic & medicinal chemistry letters》2008,18(17):4859-4863
A series of 1,3-disubstituted-1H-pyrrole-based antagonists of the human Melanin-Concentrating Hormone Receptor 1 (h-MCH-R1) are reported. High-throughput screening of the AstraZeneca compound collection yielded 1, a hit with moderate affinity towards MCH-R1. Subsequent structural manipulations and SAR analysis served to rationalize potency requirements, and 12 was identified as a novel, functional MCH-R1 antagonist with favorable pharmacokinetic properties. 相似文献
5.
Sasmal S Balaji G Kanna Reddy HR Balasubrahmanyam D Srinivas G Kyasa S Sasmal PK Khanna I Talwar R Suresh J Jadhav VP Muzeeb S Shashikumar D Harinder Reddy K Sebastian VJ Frimurer TM Rist Ø Elster L Högberg T 《Bioorganic & medicinal chemistry letters》2012,22(9):3157-3162
Melanin concentrating hormone (MCH) is an important mediator of energy homeostasis and plays a role in metabolic and CNS disorders. The modeling-supported design, synthesis and multi-parameter optimization (biological activity, solubility, metabolic stability, hERG) of novel quinazoline derivatives as MCHR1 antagonists are described. The in vivo proof of principle for weight loss with a lead compound from this series is exemplified. Clusters of refined hMCHR1 homology models derived from the X-ray structure of the β2-adrenergic receptor, including extracellular loops, were developed and used to guide the design. 相似文献
6.
Sasmal S Balasubrahmanyam D Kanna Reddy HR Balaji G Srinivas G Cheera S Abbineni C Sasmal PK Khanna I Sebastian VJ Jadhav VP Singh MP Talwar R Suresh J Shashikumar D Harinder Reddy K Sihorkar V Frimurer TM Rist Ø Elster L Högberg T 《Bioorganic & medicinal chemistry letters》2012,22(9):3163-3167
Melanin concentrating hormone receptor 1 (MCHR1) antagonists have potential for the treatment of obesity and several CNS disorders. In the preceding article, we have described a novel series of quinazolines as MCHR1 antagonists and demonstrated in vivo proof of principle with an early lead. Herein we describe the detailed SAR and SPR studies to identify an optimized lead candidate having good efficacy in a sub-chronic DIO model with a good cardiovascular safety window. 相似文献
7.
Lim CJ Kim N Lee EK Lee BH Oh KS Yoo SE Yi KY 《Bioorganic & medicinal chemistry letters》2011,21(8):2309-2312
Compounds containing 2-arybenzimidazole ring systems linked to arylpiperidines were synthesized and evaluated as MCH-R1 antagonists. The results of structure-activity relationship studies led to the identification of compound 4c as a potent MCH-R1 antagonist (IC50 = 1 nM). This compound also has good metabolic stability, and favorable pharmacokinetic and brain penetration properties. However 4c was found to be potent inhibitor of the hERG potassium channel. 相似文献
8.
Zhang M Tamiya J Nguyen L Rowbottom MW Dyck B Vickers TD Grey J Schwarz DA Heise CE Haelewyn J Mistry MS Goodfellow VS 《Bioorganic & medicinal chemistry letters》2007,17(9):2535-2539
A series of thienopyrimidinone bis-aminopyrrolidine ureas were designed, synthesized, and evaluated for their ability to bind melanin-concentrating hormone receptor-1. These compounds exhibit potent binding affinity (K(i)=3 nM) and good in vitro metabolic stability. 相似文献
9.
Pradip K. Sasmal Sanjita Sasmal P. Tirumala Rao B. Venkatesham M. Roshaiah Chandrasekhar Abbineni Ish Khanna Vikram P. Jadhav J. Suresh Rashmi Talwar Syed Muzeeb Jean-Marie Receveur Thomas M. Frimurer Øystein Rist Lisbeth Elster Thomas Högberg 《Bioorganic & medicinal chemistry letters》2010,20(18):5443-5448
Melanin concentrating hormone (MCH) is an important mediator of energy homeostasis and plays role in several disorders such as obesity, stress, depression and anxiety. The synthesis and biological evaluation of novel benzimidazole derivatives as MCHR1 antagonists are described. The in vivo proof of principle for weight loss with a lead compound from this series is exemplified. 相似文献
10.
Susanne Berglund Bryan J. Egner Henrik Gradén Joakim Gradén David G.A. Morgan Tord Inghardt Fabrizio Giordanetto 《Bioorganic & medicinal chemistry letters》2009,19(15):4268-4273
Herein, we disclose the discovery and optimization of 2-piperidin-4-yl-acetamide derivatives as MCH-R1 antagonists. Structural investigation of piperidin-4-yl-amide and piperidin-4-yl-ureas identified 2-piperidin-4-yl-acetamide-based MCH-R1 antagonists with outstanding in vivo efficacy but flawed with high affinity towards the hERG potassium channel. While existing hERG SAR information was employed to discover highly potent MCH-R1 antagonists with minimized hERG inhibition, additional hurdles prevented their subsequent clinical exploration. 相似文献
11.
Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists
Vasudevan A Souers AJ Freeman JC Verzal MK Gao J Mulhern MM Wodka D Lynch JK Engstrom KM Wagaw SH Brodjian S Dayton B Falls DH Bush E Brune M Shapiro RD Marsh KC Hernandez LE Collins CA Kym PR 《Bioorganic & medicinal chemistry letters》2005,15(23):5293-5297
The synthesis and biological evaluation of novel 3-amino indazole melanin concentrating hormone receptor-1 antagonists are reported, several of which demonstrated functional activity of less than 100nM. Compounds 19 and 28, two of the more potent compounds identified in this study, were characterized by high exposure in the brain and demonstrated robust efficacy when dosed in diet-induced obese mice. 相似文献
12.
Makoto Ando Etsuko Sekino Yuji Haga Minoru Moriya Masahiko Ito Junko Ito Hisashi Iwaasa Akane Ishihara Akio Kanatani Norikazu Ohtake 《Bioorganic & medicinal chemistry letters》2009,19(17):5186-5190
Novel phenethylpyridone derivatives were identified as potent human melanin-concentrating hormone 1 receptor (MCH-1R) antagonists. A search for surrogates for the 4-(2-aminoethoxy)phenyl moiety of 1 resulted in discovery of 2-[4-(aminomethyl)phenyl]ethyl substructure as in 6a. Successive optimization of the right-hand moiety led to the identification of a number of potent derivatives. 相似文献
13.
Susanne Berglund Bryan J. Egner Henrik Gradén Joakim Gradén David G.A. Morgan Tord Inghardt Fabrizio Giordanetto 《Bioorganic & medicinal chemistry letters》2009,19(15):4274-4279
The discovery and optimization of piperidin-4-yl-urea derivatives as MCH-R1 antagonists is herein described. Previous work around the piperidin-4-yl-amides led to the discovery of potent MCH-R1 antagonists. However, high affinity towards the hERG potassium channel proved to be an issue. Different strategies to increase hERG selectivity were implemented and resulted in the identification of piperidin-4-yl-urea compounds as potent MCH-R1 antagonists with minimized hERG inhibition. 相似文献
14.
Xu R Li S Paruchova J McBriar MD Guzik H Palani A Clader JW Cox K Greenlee WJ Hawes BE Kowalski TJ O'Neill K Spar BD Weig B Weston DJ 《Bioorganic & medicinal chemistry》2006,14(10):3285-3299
Melanin concentrating hormone (MCH) receptor antagonists have been proposed as potential treatments of obesity. MCH receptor antagonists with a biphenylamine subunit have been reported previously at Schering-Plough. Herein, we report the discovery of bicyclo[4.1.0]heptanes as replacements for the middle phenyl ring of the biphenylamine moiety in order to eliminate its potential mutagenic liability. Structure-activity relationships in this series were found to be very similar to those of the original biphenylamine series, suggesting that the two series have similar binding modes. 相似文献
15.
《Bioorganic & medicinal chemistry letters》2014,24(23):5493-5496
2-Aminopyrimidin-4(1H)-one was proposed as the novel bioisostere of urea. Bioisosteric replacement of the reported urea series of the CXCR2 antagonists with 2-aminopyrimidin-4(1H)-ones led to the discovery of the novel and potent CXCR2 antagonist 3e. 2-Aminopyrimidin-4(1H)-one derivative 3e demonstrated a good developability profile (reasonable solubility and high permeability) and superior chemical stability especially in simulated gastric fluid (SGF) compared with ureas. 相似文献
16.
Dengyou Zhang Jing Ai Zhongjie Liang Wei Zhu Xia Peng Xianjie Chen YinChun Ji Hualiang Jiang Cheng Luo Meiyu Geng Hong Liu 《Bioorganic & medicinal chemistry letters》2013,23(8):2408-2413
A series of novel 5-(benzyloxy)pyridin-2(1H)-ones were designed, synthesized and biologically evaluated for c-Met inhibition. Various amides and benzoimidazoles at C-3 position were investigated. A potent compound 12b with a c-Met IC50 of 12 nM was identified. This compound exhibited potent inhibition of EBC-1 cell associated with c-Met constitutive activation and showed high selectivity for c-Met than other tested 11 kinases. The binding model 12b with c-Met was disclosed by docking analysis. 相似文献
17.
Zhong W Liu H Kaller MR Henley C Magal E Nguyen T Osslund TD Powers D Rzasa RM Wang HL Wang W Xiong X Zhang J Norman MH 《Bioorganic & medicinal chemistry letters》2007,17(19):5384-5389
Cyclin-dependent kinase 5 (CDK5) is a serine/threonine protein kinase and its deregulation is implicated in a number of neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, and ischemic stroke. Using active site homology modeling between CDK5 and CDK2, we explored several different chemical series of potent CDK5 inhibitors. In this report, we describe the design, synthesis, and CDK5 inhibitory activities of quinolin-2(1H)-one derivatives. 相似文献
18.
To identify possible ligands of the orphan somatostatin-like receptor 1 (SLC-1), rat brain extracts were analyzed by using the functional expression system of Xenopus oocytes injected with cRNAs encoding SLC-1 and G protein-gated inwardly rectifying potassium channels (GIRK). A strong inward current was observed with crude rat brain extracts which upon further purification by cation exchange chromatography and high performance liquid chromatography (HPLC) yielded two peptides with a high agonist activity. Mass spectrometry and partial peptide sequencing revealed that one peptide is identical with the neuropeptide melanin concentrating hormone (MCH), the other represents a truncated version of MCH lacking the three N-terminal amino acid residues. Xenopus oocytes expressing the MCH receptor responded to nM concentrations of synthetic MCH not only by the activation of GIRK-mediated currents but also by the induction of Ca(2+) dependent chloride currents mediated by phospholipase C. This indicates that the MCH receptor can couple either to the G(i)- or G(q)-mediated signal transduction pathway, suggesting that MCH may serve for a number of distinct brain functions including food uptake behavior. 相似文献
19.
Kanuma K Omodera K Nishiguchi M Funakoshi T Chaki S Semple G Tran TA Kramer B Hsu D Casper M Thomsen B Beeley N Sekiguchi Y 《Bioorganic & medicinal chemistry letters》2005,15(10):2565-2569
A series of 4-(dimethylamino)quinazoline based antagonists of the melanin-concentrating hormone receptor 1 (MCH-R1) is described. This series was derived from a lead compound, AR129330, identified by HTS of a GPCR-directed library using a functional assay with a constitutively activated (CART) form of the receptor. The preliminary optimization resulted in the identification of compounds 20, 21, and 23. 相似文献
20.
Takao Suzuki Minoru Moriya Toshihiro Sakamoto Takuya Suga Hiroyuki Kishino Hidekazu Takahashi Makoto Ishikawa Keita Nagai Yumiko Imai Etsuko Sekino Masahiko Ito Hisashi Iwaasa Akane Ishihara Shigeru Tokita Akio Kanatani Nagaaki Sato Takehiro Fukami 《Bioorganic & medicinal chemistry letters》2009,19(11):3072-3077
Optimization of high-throughput screening hit 1a led to the identification of a novel spiro-piperidine class of melanin-concentrating hormone 1 receptor (MCH-1R) antagonists. Compound 3c was identified as a highly potent and selective MCH-1R antagonist, which has an IC50 value of 0.09 nM at hMCH-1R. The synthesis and structure–activity relationships of the novel spiro-piperidine MCH-1R antagonists are described. 相似文献